DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Valdecoxib

Valdecoxib

  • Emerging Drug List PARECOXIB SODIUM

    Emerging Drug List PARECOXIB SODIUM

  • Development and Validation of an Ultra Performance Liquid

    Development and Validation of an Ultra Performance Liquid

  • New Restrictions on Celecoxib (Celebrex) Use and the Withdrawal of Valdecoxib (Bextra)

    New Restrictions on Celecoxib (Celebrex) Use and the Withdrawal of Valdecoxib (Bextra)

  • Non Steroidal Anti-Inflammatory Drugs

    Non Steroidal Anti-Inflammatory Drugs

  • Metabolic Profiling of Murine Plasma Reveals an Unexpected Biomarker In

    Metabolic Profiling of Murine Plasma Reveals an Unexpected Biomarker In

  • Bextra, INN-Valdecoxib

    Bextra, INN-Valdecoxib

  • Received July 12, 2005, Accepted October 18, 2005 V. Ciddi University College of Pharmaceutical Sciences, Kakatiya University, W

    Received July 12, 2005, Accepted October 18, 2005 V. Ciddi University College of Pharmaceutical Sciences, Kakatiya University, W

  • Emerging Drug List — Valdecoxib

    Emerging Drug List — Valdecoxib

  • Acute Congestive Heart Failure Induced by Rofecoxib

    Acute Congestive Heart Failure Induced by Rofecoxib

  • Parecoxib (As Sodium)

    Parecoxib (As Sodium)

  • Is Ketorolac Safe for Use After Cardiac Surgery?

    Is Ketorolac Safe for Use After Cardiac Surgery?

  • A High Level of Cyclooxygenase-2 Inhibitor Selectivity Is Associated with a Reduced Interference of Platelet Cyclooxygenase-1 Inactivation by Aspirin

    A High Level of Cyclooxygenase-2 Inhibitor Selectivity Is Associated with a Reduced Interference of Platelet Cyclooxygenase-1 Inactivation by Aspirin

  • Plants As Sources of Anti-Inflammatory Agents

    Plants As Sources of Anti-Inflammatory Agents

  • Valdecoxib Tablets

    Valdecoxib Tablets

  • Effects of Parecoxib, a Parenteral COX-2–Specific Inhibitor, on The

    Effects of Parecoxib, a Parenteral COX-2–Specific Inhibitor, on The

  • Review Article Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: a Systematic Review of Randomized Controlled Trials

    Review Article Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: a Systematic Review of Randomized Controlled Trials

  • National PBM Drug Monograph Valdecoxib (Bextra®) VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel

    National PBM Drug Monograph Valdecoxib (Bextra®) VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel

  • Original Research

    Original Research

Top View
  • Appendix A. Pharmacokinetics, Indications and Dosing of Included Drugs
  • Synthesis, Spectral Studies, Hydrolysis Kinetics and Pharmacodynamic Profile of Mefenamic Acid Prodrugs
  • 1 BEXTRA® 2 Valdecoxib Tablets 3
  • PRODUCT INFORMATION COX Inhibitor Pack Item No
  • Voluntary Withdrawal of Rofecoxib (Vioxx)
  • Decisional Summary
  • Title. Valdecoxib: the Rise and Fall of a COX-2 Inhibitor Abstract Introduction: Valdecoxib Is a Cyclooxygenase 2 (COX-2) Selec
  • Membrane Interactivity of Non-Steroidal Anti-Inflammatory Drugs: a Literature Review
  • Non-Steroidal Antiinflammatory Drugs (Nsaids)
  • Medicines Adverse Reactions Committee
  • Cost-Effectiveness of Valdecoxib Compared to Diclofenac in Patients with Rheumatoid Arthritis (Ra) in the United Kingdom (Uk) and Germany R
  • Safety Review: Nonsteroidal Anti-Inflammatory Drugs (Nsaids) and Spontaneous Abortion
  • Regulatory History of the Interaction Between Aspirin and Other
  • Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: an Update
  • JFP Right Ballpark, Wrong Base: Assessing Safety of Nsaids
  • Bextra, INN-Valdecoxib


© 2024 Docslib.org    Feedback